INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹56 Cr | ₹435 Cr | ₹584 Cr | ₹80 Cr | ₹27 Cr |
What is the latest Total Non-Current Liabilities ratio of INDEGENE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹56 Cr |
Mar2024 | ₹435 Cr |
Mar2023 | ₹584 Cr |
Mar2022 | ₹80 Cr |
Mar2021 | ₹27 Cr |
How is Total Non-Current Liabilities of INDEGENE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹56 Cr | -87.12 | |
Mar2024 | ₹435 Cr | -25.54 | |
Mar2023 | ₹584 Cr | 630.10 | |
Mar2022 | ₹80 Cr | 198.58 | |
Mar2021 | ₹27 Cr | - |
Compare Total Non-Current Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,879.0 Cr | 2.4% | -1.4% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 2.4% |
-1.4% |
0.8% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses